May 16, 2011 ChromaCon and Merus Biopharmaceuticals awared with Eurostars grant
Press Release
ChromaCon and Merus Biopharmaceuticals awared with Eurostars grant
Zurich, May 16, 2011. Merus BV and ChromaCon AG announced today the award of an EUREKA Eurostars grant with a total budget of €1.8 million to discover and develop bispecific antibodies for treatment of metastatic breast cancer. (press release)